@prefix dcterms: . @prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix go: . @prefix obo: . @prefix Protein: . @prefix hgnc: . @prefix geneProductOf: . @prefix hasPart: . @prefix ProteinComplex: . @prefix hasAgent: . @prefix schem: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasAgent: sub:_2; a go:0003824 . sub:_2 hasPart: sub:_3, sub:_4, sub:_5; a ProteinComplex: . sub:_3 geneProductOf: hgnc:2204; a Protein: . sub:_4 geneProductOf: hgnc:6141; a Protein: . sub:_5 geneProductOf: hgnc:6156; a Protein: . sub:_6 occursIn: obo:UBERON_0002367, species:9606; rdf:object schem:cyclic%20AMP; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "cat(complex(p(HGNC:COL4A3),p(HGNC:ITGA5),p(HGNC:ITGB3))) -> a(SCHEM:\"cyclic AMP\")" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_8; pav:version "20131211" . sub:_7 prov:value "Furthermore, cells treated with CD47/IAP- or the alpha(v)beta3 integrin-reactive antibodies prevented the alpha3(IV)185-203 peptide from inhibiting cell proliferation and the subsequent rise in intracellular cAMP"; prov:wasQuotedFrom pubmed:10493512 . sub:_8 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:10493512; prov:wasDerivedFrom beldoc:, sub:_7 . } sub:pubinfo { this: dcterms:created "2014-07-03T14:31:31.982+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }